ALNYLAM PHARMACEUTICALS, INC.
Lobbying client. Federal LDA filings.
- Source id
57163- General description
- Pharmaceutical manufacturer
- State
- MA
- Country
- US
- Principal place of business
- US
- Effective date
- 2023-07-01
- Total spend (across 1 ingested filings)
- $0
Filings (1) — $0
| Posted | Type | Year | Lobbying firm | Income |
|---|---|---|---|---|
| 2026-04-20 | Q1 | 2026 | ALNYLAM PHARMACEUTICALS, INC. | — |
Connected on the graph
10 typed relationships in the influence graph — 10 inbound, 0 outbound, grouped by type.
lobbied for (10)
| date | dir | entity | amount | role | source |
|---|---|---|---|---|---|
| — | ← | Curtis Rhyne | — | lda_lobbyist_client | |
| — | ← | Katherine Fleming Cotton | — | lda_lobbyist_client | |
| — | ← | Amy Jensen | — | lda_lobbyist_client | |
| — | ← | Daniel M Todd | — | lda_lobbyist_client | |
| — | ← | Ted Lehman | — | lda_lobbyist_client | |
| — | ← | Sarah Kuehl Egge | — | lda_lobbyist_client | |
| — | ← | Nicolas Magallanes | — | lda_lobbyist_client | |
| — | ← | Eric Bergren | — | lda_lobbyist_client | |
| — | ← | Deirdre Bradford Parsons | — | lda_lobbyist_client | |
| — | ← | Paul Edattel | — | lda_lobbyist_client |